TIC.NYSEAcuren CORP

Form 4: ACUREN Director Peter Hochfelder Converts RSUs to Common Stock, Receives New Grant

Sentiment:

Insider Transaction Report


ACUREN Corp Director Peter A. Hochfelder reported the settlement of 10,000 restricted stock units into common stock and the grant of 9,017 new restricted stock units.

Summary

  • Peter A. Hochfelder, a Director of ACUREN CORP (TIC), reported transactions involving the company's equity securities.
  • On July 30, 2025, 10,000 restricted stock units (RSUs) held by Mr. Hochfelder were settled for an equal number of shares of ACUREN's Common Stock.
  • These 10,000 restricted stock units vested on July 30, 2025, which was the one-year anniversary of their grant date.
  • Following this transaction, Mr. Hochfelder beneficially owned 10,000 shares of Common Stock directly.
  • On July 31, 2025, Mr. Hochfelder was granted 9,017 new restricted stock units.
  • Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  • The newly granted 9,017 restricted stock units are scheduled to vest on July 31, 2026, which is the one-year anniversary of their grant date.
  • After the new grant, Mr. Hochfelder beneficially owned 9,017 derivative securities (restricted stock units) directly.

Sentiment

Score: 7

Explanation: The filing indicates a director's continued equity participation through RSU settlement and a new grant, which is generally a positive sign of alignment with shareholder interests and ongoing commitment to the company.

Positives

  • A director's restricted stock units vested and converted into common stock, indicating a successful equity compensation event.
  • The director received a new grant of 9,017 restricted stock units, demonstrating continued equity incentive and alignment with shareholder interests.

Future Outlook

The newly granted 9,017 restricted stock units are expected to vest on July 31, 2026, further aligning the director's interests with the company's long-term performance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, specifically related to equity compensation for a director. Such filings are common across all publicly traded companies as part of their compliance with SEC regulations, reflecting standard practices for executive and director compensation through equity awards.

Stakeholder Impact

  • Shareholders: The director's continued equity ownership and new RSU grant align their interests with shareholders, potentially fostering long-term value creation.

Next Steps

  • Vesting of the 9,017 restricted stock units on July 31, 2026.

Key Dates

DateDescription
07/30/202510,000 restricted stock units vested and were settled for an equal number of shares of Common Stock.
07/31/20259,017 new restricted stock units were granted.
08/01/2025Date the Form 4 was signed by the Attorney-in-Fact.
07/31/2026Vesting date for the 9,017 newly granted restricted stock units.

Recommendation

hold

This Form 4 details a director's equity transactions, including the settlement of restricted stock units into common stock and the grant of new units. While it indicates continued alignment of the director's interests with shareholders, it does not provide sufficient financial or strategic information to warrant a 'buy' or 'sell' recommendation. It's a routine compensation disclosure.

Keywords

ACUREN CORP, TIC, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Common Stock, Peter A. Hochfelder, Director Compensation, Equity Incentive

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.